Pharmacy alerts
-
Quadrant Pharmaceuticals Limited, Vesomni 6 mg/0.4 mg modified release tablets defect
Class 4 medicines defect: The MHRA has published a Class 4 medicines defect notification for Vesomni 6 mg/0.4 mg modified release tablets.
-
Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml recalled
Class 2 medicines recall: The MHRA has published a Class 2 medicines recall for Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml.
-
Outbreak of invasive meningococcal disease, South East England
Update: UKHSA outlines priority steps to reduce the risk of infection spreading.
-
Outbreak of meningococcal disease linked to University of Kent and the area of Canterbury (England)
Support alert: UKHSA and NHS England have issued a letter regarding the outbreak of meningococcal disease linked to University of Kent and the area of Canterbury.
-
Baxter Healthcare Corporation, Onkotrone Injection 2 mg/ml concentrate for solution for infusion defect
Class 4 medicines defect notification: The MHRA has published a Class 4 medicines defect notification for Onkotrone Injection 2 mg/ml concentrate for solution for infusion.
-
Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml) recalled
Class 2 medicines recall: The MHRA has published a Class 2 medicines recall for specific batches of Curaleaf Oil [FS] 10mg/ml THC 10mg/ml CBD (30ml).